MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$22,392K
(4.56%↑ Y/Y)
Other income, net
$16,411K
(-17.22%↓ Y/Y)
Gross product revenue
$37,307K
Interest income
$511K
(-48.90%↓ Y/Y)
Loss before income
taxes
-$22,391K
(4.42%↑ Y/Y)
Income tax provision
$1K
(-97.22%↓ Y/Y)
Total other income,
net
$4,369K
(-55.55%↓ Y/Y)
Product
$29,163K
(38.52%↑ Y/Y)
License And Other
$5,903K
(-34.13%↓ Y/Y)
Interest expense
$12,553K
(14.18%↑ Y/Y)
Provisions for product
revenue
$8,144K
Loss from operations
-$26,760K
(19.53%↑ Y/Y)
Revenue from contract
with customer,...
$35,066K
(16.83%↑ Y/Y)
Total operating
expenses
$61,826K
(-2.28%↓ Y/Y)
Research and development
$33,797K
(-2.37%↓ Y/Y)
Selling, general and
administrative
$26,684K
(-2.44%↓ Y/Y)
Cost of sales
$1,345K
(3.38%↑ Y/Y)
Back
Back
Income Statement
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)
source: myfinsight.com